​Kembara Xtra - Medicine - Hyperprolactinemia

​Kembara Xtra - Medicine - Hyperprolactinemia
When the lactotroph cells of the pituitary gland are affected either physiologically or pathologically, the result is hyperprolactinemia, which is an abnormal spike in serum prolactin levels.

Prevalence of Epidemiology
Predominant sex: female (70%) > male (30%) Predominant age: reproductive age
Men come with headache, visual abnormalities, and erectile dysfunction; women are more likely to experience changes in menstruation and galactorrhea, and men have adenomas that are often larger due to the delayed start of symptoms.


Pathophysiology and Etiology 

 The anterior pituitary's lactotrophs, which make prolactin, are controlled by: - Dopamine and other inhibitory substances are produced in the hypothalamus and transported to the pituitary stalk by the hypothalamic-pituitary arteries.
Thyrotropin-releasing hormone (TRH) is the main stimulatory agent.
● The following are some examples of hyperprolactinemia causes: - Physical
- Increased estrogen-related pregnancy
- Nursing or nipple stimulation - Stress, including the aftermath of surgery
- Pharmaceuticals Usually, concentrations fall between 20 and 100 ng/mL (2)[A].
Prochlorperazine and metoclopramide are two dopamine (D2) blockers. Antidepressants include tricyclic antidepressants (TCAs); paroxetine (an SSRI) induces transitory hyperprolactinemia, which typically recovers in 7 to 10 days. Dopamine depleters include methyldopa and reserpine. Verapamil (but not other calcium channel blockers; believed to reduce hypothalamic dopamine production) Older antipsychotics include haloperidol, fluphenazine, and risperidone (the level of elevation with risperidone is higher than with other antipsychotics). Newer antipsychotics include asenapine, iloperidone, and lurasidone, which may cause elevation but do so less frequently than the older antipsychotics.
- Hypothyroidism brought on by increased TRH
Herpes zoster, trauma, or post-thoracotomy disorders of the chest wall; prolactin-secreting adenoma in the anterior pituitary (microadenoma: 1 cm; macroadenoma: >1 cm). Pituitary stalk disruption or compression
Meningioma, astrocytoma, Craniopharyngioma, Rathke Cleft Cyst
Metastases and head injury
 Infiltrative and inflammatory conditions
- Reduced prolactin clearance (cirrhosis, cocaine, chronic renal failure) - Idiopathic hyperprolactinemia, which occurs often in people with serum prolactin levels between 20 and 100 ng/mL for no apparent reason.

Based on clinical history, physical examination, and laboratory results, a diagnosis is made. 

The following symptoms and indicators of pituitary enlargement may also be present: Galactorrhea, amenorrhea or oligomenorrhea, infertility, osteoporosis or osteoopenia, decreased libido, impotence, and weight gain. - Headache - Bitemporal hemianopia, a visual field impairment
- Hypopituitarism (a result of the tumor's strain on nearby structures).
Additionally, they could exhibit symptoms of comorbid conditions: - Cushing disease - Hypothyroidism
Acromegaly and MEN-1 syndrome, or multiple endocrine neoplasia,

Clinical evaluation, visual field tests, cranial nerve examination, and examination for lesions on the chest wall 


Multiple Diagnoses 
Macroprolactinemia: While not biologically active, macroprolactin, a polymer of multiple prolactin units, is detectable by immunologically based laboratory testing. Consider this diagnosis and inform the lab if the patient has increased prolactin (PRL) despite being asymptomatic. Treatment is not necessary.

Serum prolactin (most reliable results if examined fasting, in the morning; eating only has a modest effect on concentrations, therefore fasting is not essential, but if elevated levels recur on a fasting samples) is a laboratory finding that can be used to diagnose many diseases. In postmenopausal women, a value of >25 g/L is abnormal, >25 g/L is normal, and >30 g/L or more frequently denotes a prolactinoma.

Luteinizing hormone (LH)/follicle-stimulating hormone (FSH) if amenorrheic; pregnancy test; thyroid-stimulating hormone (TSH); Initial Chem Panel Tests (Lab, Imaging)

A single blood prolactin test can confirm the diagnosis if the result is higher than the upper limit of normal.
Pituitary MRI: the best imaging modality. 
Levels should be obtained before a breast exam and a CT scan should be done if an MRI is not appropriate.

Tests in the Future & Special Considerations

formal visual field testing if there is a suspicion of a pituitary adenoma

Management 
Stop using any problematic medications, if any.
Treat the root causes.
Observation alone may be an option for asymptomatic people with minor prolactin increases.

● Medications recommended for: - Hypogonadism symptoms, such as decreased libido
- Galactorrhea, if the patient finds it irritating
- Fertility is restored
- A pituitary tumor
- Combating osteoporosis

Dopamine agonist medications: Lower serum prolactin levels and shrink most lactotroph adenomas in size.
Due to its effectiveness and manageable adverse effect profile, cabergoline (Dostinex) is now the first-line option. It is dosed at 0.25 mg twice weekly or 0.50 mg once weekly.
The reduction of chronic hyperprolactinemia, galactorrhea, and amenorrhea/oligomenorrhea was more pronounced with cabergoline than with bromocriptine, despite the latter being more expensive. Has been demonstrated to lessen erectile dysfunction in hyperprolactinemic men; has recently been linked to significant improvements in body mass index, total HDL and LDL cholesterol levels, and insulin sensitivity; a decrease in proinflammatory markers; and a reduction in carotid intima-media thickness.– Adverse effects (better tolerated if administered at night with food and at low doses with slow titration):  Nausea/vomiting Headache, lightheadedness, and exhaustion
Contraindications for postural hypotension
Unmanageable hypertension
Cardiac valvular illnesses
 Fibrotic conditions of the pericardium, the lungs, or the retroperitoneum
Bromocriptine (Parlodel): This medication has the longest clinical history and is chosen by certain clinicians when treating infertility. It is dosed BID; start with 1.25 mg once at bedtime or after supper for a week, then increase to BID. Both are efficient in shrinking tumors and easing symptoms.

SE is diminished by cabergoline compared to bromocriptine (5)[A].
In the US, pergolide (Permax) is no longer in use.
Don't stop the medication suddenly if the patient is still taking it.
ADVANCED THERAPIES
Prolactin levels were reduced in virtually all patients with radiation, and in over 25% of patients with low complication rates, in those with medically and surgically refractory prolactinomas.

Surgical procedures Medical treatment for adenomas is effective in 80–90% of individuals. In some circumstances, surgery is advised: - Resistance or intolerance to medical care - Headache
- Loss of visual acuity - CSF leak from tumor apoplexy or shrinking
A high recurrence rate (up to 40%), CSF leakage, meningitis, pituitary insufficiency, and temporary diabetes insipidus are among the risks associated with cranial nerve deficiency.


Take Action 

After one month, recheck the lab results; if they are normal, continue the initial dose. Increase cabergoline to 1.25 mg two to three times per week or bromocriptine to 5 mg twice day if lab levels do not drop but the patient shows no negative effects.
patient observation

 If there is no tumor and prolactin levels are normal after at least 2 years of treatment, one might think about reducing and ceasing medication. However, this decision must be carefully monitored because the tumor could recur.
Take into account: - Annual formal visual field assessment - Serial MRIs if clinically necessary 
pregnant women's issues

Dopamine agonists are indicated for usage if neurologic symptoms are present but are not approved for use during pregnancy or if pregnancy is confirmed in a woman with hyperprolactinemia who wishes to get pregnant.

Bromocriptine should be used to treat microprolactinoma if symptoms are present. Pregnancy should be confirmed monthly before stopping bromocriptine.
With macroprolactinomas, a specific, personal plan is created. Options include stopping bromocriptine at conception and carefully monitoring prolactin levels and VS, with or without MRI scan evidence of tumor enlargement; prenatal transsphenoidal surgery with tumor debulking; and continued bromocriptine use throughout pregnancy, with a risk to the fetus.
Careful monitoring of visual fields during each trimester; prolactin levels are not need to be checked as they are often elevated owing to pregnancy.

Educating the Patient 

Talk about the dangers of untreated hyperprolactinemia.
Headache, reduced visual acuity, weakened bones, and infertility


Prognosis: If PRL levels have stayed normal for 1 to 2 years after therapy, you could want to discontinue taking your medications.
Approximately 5–10% of macroadenomas can develop into macroadenomas.
Follow-up imaging is not necessary unless there are indications of a growing malignancy. >10 years, 7% probability of prolactin-secreting microadenoma progression 


Complications: For patients on large doses of cabergoline, cardiac US is advised every two years. If a pituitary adenoma develops, there is a risk of permanent visual field loss.